WHAT TYPE OF STUDY IS OUR RESEARCH STUDY?
Our Heart Study is a graduate student dissertation.
WHO ARE THE STUDY INVESTIGATORS?
The Principal Investigator is Torhonda C. Lee, PhD, Associate Professor
Florida A&M University.
The Co-Principal Investigator is Windy Y. Cunningham, M.S., Doctoral Candidate
Florida A&M University.
IS THIS STUDY APPROVED?
This study is approved by the Institutional Review Board of Florida A&M University.
WHO IS ELIGIBLE TO PARTICIPATE?
Our Heart Study is for Black women over the age of 18 that live in North Carolina, Georgia, Alabama and North Florida
HOW CAN I PARTICIPATE IN OUR HEART STUDY?
There are two Phases of Our Heart Study.
Participants in Phase I and Phase II must sign an Informed Consent Form before participating in Our Heart Study.
Participation in Phase I is closed to enrollment.
Enrollment in Phase II is open to Black women living in North Carolina, Georgia Alabama and North Florida.
HOW CAN I TAKE THE ONLINE QUESTIONNAIRE?
The questionnaire link is:
HOW MANY PARTICIPANTS ARE NEEDED FOR PHASE II?
More than 350 Black women
HOW MUCH TIME DOES IT TAKE TO COMPLETE THE ONLINE QUESTIONNAIRE?
It takes about 10 minutes to complete the online questionnaire.
WILL I GET PAID TO PARTICIPATE IN OUR HEART STUDY?
Participants in Phase II will be entered into a raffle to win one of two $50 gift cards.
WHAT WILL THE RESEARCHERS DO WITH MY DATA?
Participation in Our Heart Study is completely anonymous. No one will be able to identify the participants nor can the information provided be linked to the participants. Only the researchers will have access to the data provided.
The researchers will use the data to gain an increased understanding of the roles of adverse childhood experiences, coping style, and social support influence heart disease risk in Black women. This knowledge may inform strategies for improving Black women’s health and increasing awareness about specific types of risk for cardiovascular disease.
DOES THIS STUDY INVOLVE AN INVESTIGATIONAL DRUG?
This study does not involve an investigational drug and it is not a medical experiment. Participants will not provide blood or any other biological samples.
